Avid Bioservices Inc (CDMO)

[biopharm]

Dr Jedd Wolchok Jan 2018 appearance wonder if there are nondisclosures for this conference, as I still see Tesaro has nondisclosures in IO pipeline (very possible tied to PS Targeting)

_______


T Cell Dysfunction, Cancer and Infection (A3)

Scientific Organizers: Daniel C. Douek, W. Nicholas Haining and Jedd D. Wolchok

January 16—20, 2018
Beaver Run Resort, Breckenridge, Colorado, USA

Sponsored by Incyte Corporation, Juno Therapeutics and TESARO, Inc.

...
...

Philip D. Greenberg, University of Washington, USA
Novel Approaches to Isolating Receptors and Engineering Cells to Target Tumor Antigens

...
...

Jedd D. Wolchok, Memorial Sloan-Kettering Cancer Center, USA
Clinical Results of Combined Checkpoint Blockades
...

https://www.keystonesymposia.org/index.cfm?e=web.Meeting.Program&meetingid=1545

_________


https://www.linkedin.com/in/lena-evilevitch-phd-4a92a68

Anyhow....Peregrine ex Medical Director Vladimir has a relative that is also Medical Director over at Tesaro

Tesaro BOD:

BOARD OF DIRECTORS
Our Board is driven by sound corporate governance.

David Mott
General Partner, New Enterprise Associates

Lawrence Alleva
Retired Partner, PriceWaterhouseCoopers

James Armitage, M.D.
Joe Shapiro Chair for the Study of Oncology and Clinical Research, University of Nebraska Medical Center

Earl (Duke) Collier, Jr.
President, The Braxton Company

Mary Lynne Hedley, Ph.D.
President, Chief Operating Officer and Co-Founder, TESARO

Lonnie Moulder
Chief Executive Officer and Co-Founder, TESARO

Garry Nicholson
President and CEO, XTuit Pharmaceuticals

Arnold Oronsky, Ph.D.
General Partner, InterWest Partners

Kavita Patel, M.D., M.S., F.A.C.P.
Senior Fellow, The Brookings Institution

Beth Seidenberg, M.D.
Partner, Kleiner Perkins Caufield & Byers



SENIOR LEADERSHIP
Our leadership team has extensive experience in developing, obtaining regulatory approvals for and successfully commercializing a variety of oncology products. In total, they have decades of combined experience spanning a range of cancers and other diseases.


Lonnie Moulder
Chief Executive Officer


Mary Lynne Hedley, Ph.D.
President, Chief Operating Officer


Stephen Andre
Senior Vice President, Human Resources


Grant Bogle
Senior Vice President, Chief Commercial Officer


Allene Diaz
Senior Vice President, Global Commercial Development


Joseph Farmer
Senior Vice President, General Counsel and Corporate Secretary


Jeffrey Hanke, Ph.D.
Executive Vice President, Research and Development, and Chief Scientific Officer


Martin Huber, M.D.
Senior Vice President, Chief Medical Officer


Jennifer Jackson, Ph.D.
Senior Vice President, Global Regulatory Affairs & Quality Assurance


Orlando Oliveira
Senior Vice President and General Manager, International


Timothy Pearson
Executive Vice President, Chief Financial Officer